Overview

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This clinical trial studies celecoxib in decreasing the damaging effects of sunburn in healthy volunteers. Celecoxib may reduce skin damage by blocking enzymes associated with sunburn in healthy volunteers.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Celecoxib